News

JOIN BSTC - Extended Deadline 23 Jan 2026
Dec 02

Call for Applications: Join the NMD4C Basic Science Trainee Committee (BSTC)

CNDR - Logo
Dec 02

CNDR Officially Launches Canadian FSHD Dataset to Support Research and Therapy Readiness

NMD4C's BSTC launches SOP database
Dec 01

Basic Science Trainee Committee Launches Pre-Clinical Science Standard Operating Procedures (SOP) Library

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG
Nov 06

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Website - 2026 NMD4C Awards - Extended Jan 23 2026
Nov 06

2026 Awards Now Open for Nominations!

AGAMREE (vamorolone) Approved treatment for DMD in Canada
Oct 03

A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada

Website - SBMA published on CMAJ.png
Oct 03

New Best Practice Recommendations for SBMA Care in Canada

2025 NMD4C ANNUAL MEETING
Oct 02

Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting